Prodrugs of A2B adenosine receptor antagonists

Details for Australian Patent Application No. 2006259411 (hide)

International Classifications

Event Publications

10 January 2008 PCT application entered the National Phase

PCT publication WO2006/138376 Priority application(s): WO2006/138376

22 October 2009 Alteration of Name

The name of the applicant has been altered to Gilead Palo Alto, Inc.

22 March 2012 Application Accepted

Published as AU-B-2006259411

29 March 2012 Assignment before Grant

Gilead Palo Alto, Inc. The application has been assigned to Gilead Sciences, Inc.

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.